Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
NDAQ:NVAX) Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development ...
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...